688566 吉贝尔
交易中 08-13 09:52:58
资讯
新帖
简况
股市必读:吉贝尔(688566)股东户数0.83万户,较上期增加9.08%
证券之星 · 08-12 01:56
股市必读:吉贝尔(688566)股东户数0.83万户,较上期增加9.08%
股市必读:吉贝尔(688566)8月7日董秘有最新回复
证券之星 · 08-10
股市必读:吉贝尔(688566)8月7日董秘有最新回复
吉贝尔:积极推进抗抑郁新药JJH201501生产批件申报工作
证券之星 · 08-07
吉贝尔:积极推进抗抑郁新药JJH201501生产批件申报工作
吉贝尔:今年上半年生产经营情况正常
证券之星 · 08-06
吉贝尔:今年上半年生产经营情况正常
股市必读:吉贝尔(688566)8月4日董秘有最新回复
证券之星 · 08-05
股市必读:吉贝尔(688566)8月4日董秘有最新回复
吉贝尔:截至2026年7月31日收市,公司股东总数为7,619户
证券之星 · 08-04
吉贝尔:截至2026年7月31日收市,公司股东总数为7,619户
每周股票复盘:吉贝尔(688566)获新型紫杉烷类化合物专利
证券之星 · 08-02
每周股票复盘:吉贝尔(688566)获新型紫杉烷类化合物专利
股市必读:新发布《吉贝尔关于获得发明专利的自愿性披露公告》
证券之星 · 07-31
股市必读:新发布《吉贝尔关于获得发明专利的自愿性披露公告》
吉贝尔:二级市场股价受多重因素影响
证券之星 · 07-29
吉贝尔:二级市场股价受多重因素影响
吉贝尔:公司主营业务持续发展,总体经营情况良好
证券之星 · 07-27
吉贝尔:公司主营业务持续发展,总体经营情况良好
股市必读:吉贝尔(688566)7月22日董秘有最新回复
证券之星 · 07-23
股市必读:吉贝尔(688566)7月22日董秘有最新回复
吉贝尔:公司将持续聚焦主营业务,夯实经营基本面
证券之星 · 07-22
吉贝尔:公司将持续聚焦主营业务,夯实经营基本面
吉贝尔:截至2026年7月20日收市,公司股东总数为7,877户
证券之星 · 07-22
吉贝尔:截至2026年7月20日收市,公司股东总数为7,877户
每周股票复盘:吉贝尔(688566)股东户数增6.51%至7938户
证券之星 · 07-19
每周股票复盘:吉贝尔(688566)股东户数增6.51%至7938户
股市必读:吉贝尔(688566)股东户数0.79万户,较上期增加6.51%
证券之星 · 07-17
股市必读:吉贝尔(688566)股东户数0.79万户,较上期增加6.51%
吉贝尔:持续聚焦主营业务,夯实经营基本面
证券之星 · 07-16
吉贝尔:持续聚焦主营业务,夯实经营基本面
吉贝尔:JJH201601已完成I期临床试验
证券之星 · 07-16
吉贝尔:JJH201601已完成I期临床试验
股市必读:吉贝尔(688566)7月6日董秘有最新回复
证券之星 · 07-07
股市必读:吉贝尔(688566)7月6日董秘有最新回复
吉贝尔:抗抑郁新药JJH201501生产批件申报工作正在有序推进中
证券之星 · 07-06
吉贝尔:抗抑郁新药JJH201501生产批件申报工作正在有序推进中
股市必读:吉贝尔(688566)7月1日董秘有最新回复
证券之星 · 07-02
股市必读:吉贝尔(688566)7月1日董秘有最新回复
加载更多
公司概况
公司名称:
江苏吉贝尔药业股份有限公司
所属行业:
医药制造业
上市日期:
2020-05-18
主营业务:
江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。公司的主要产品是利可君片、尼群洛尔片、玉屏风胶囊、醋氯芬酸肠溶片。公司是国家级专精特新“小巨人”企业。
发行价格:
23.69
{"stockData":{"symbol":"688566","market":"SH","secType":"STK","nameCN":"吉贝尔","latestPrice":26.24,"timestamp":1786585978000,"preClose":25.88,"halted":0,"volume":822423,"delay":0,"changeRate":0.0139,"floatShares":200999999,"shares":200999999,"eps":1.2634,"marketStatus":"交易中","change":0.36,"latestTime":"08-13 09:52:58","open":26.04,"high":26.47,"low":25.48,"amount":21465900,"amplitude":0.0383,"askPrice":26.33,"askSize":26,"bidPrice":26.24,"bidSize":47,"shortable":0,"etf":0,"ttmEps":1.2634,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1786591800000},"marketStatusCode":2,"adr":0,"adjPreClose":25.88,"symbolType":"stock_kcb","openAndCloseTimeList":[[1786584600000,1786591800000],[1786597200000,1786604400000]],"highLimit":28.47,"lowLimit":23.29,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":201101625,"isCdr":false,"pbRate":2.1,"roa":"--","peRate":20.769353,"roe":"1.71%","epsLYR":1.31,"committee":-0.518672,"marketValue":5277000000,"turnoverRate":0.0041,"status":0,"floatMarketCap":5277000000},"requestUrl":"/m/hq/s/688566","defaultTab":"news","newsList":[{"id":"2658291732","title":"股市必读:吉贝尔(688566)股东户数0.83万户,较上期增加9.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658291732","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658291732?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:56","pubTimestamp":1786470975,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘,吉贝尔报收于25.55元,上涨0.16%,换手率1.16%,成交量2.34万手,成交额5987.75万元。股本股东变化:截至2026年8月10日,吉贝尔股东户数为8311.0户,较7月31日增加692.0户,增幅9.08%。户均持股数量由上期的2.64万股减少至2.42万股,户均持股市值为61.73万元。董秘最新回复投资者: 请问截止8月10日,股东人数是多少?截至2026年8月10日收市,公司股东总数为8,311户。公司股东情况敬请关注公司披露的定期报告。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658704686","title":"股市必读:吉贝尔(688566)8月7日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2658704686","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658704686?lang=zh_cn&edition=full","pubTime":"2026-08-10 01:27","pubTimestamp":1786296429,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘,吉贝尔报收于25.14元,上涨2.4%,换手率1.21%,成交量2.43万手,成交额6033.37万元。董秘最新回复投资者: 最近公司股价阶段性新低,很多投资者关心并且提过建议,希望公司可以增持,回购等等措施,来提振股价,但是公司每次都表示考虑。何时可以全面反馈,需要整改内容多不多董秘: 尊敬的投资者,您好!当日关注点交易信息汇总:8月7日主力资金净流出1168.68万元,占总成交额19.37%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081000000629.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657198936","title":"吉贝尔:积极推进抗抑郁新药JJH201501生产批件申报工作","url":"https://stock-news.laohu8.com/highlight/detail?id=2657198936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657198936?lang=zh_cn&edition=full","pubTime":"2026-08-07 17:00","pubTimestamp":1786093246,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔(688566)08月07日在投资者关系平台上答复投资者关心的问题。投资者提问:cde会议进展如何?何时可以全面反馈,需要整改内容多不多吉贝尔回复:尊敬的投资者,您好!目前,公司正在按照有关申报要求积极推进抗抑郁新药JJH201501生产批件申报工作,已与相关部门完成多轮申报前的会议沟通工作;公司将依据有关要求进一步完善相关工作后正式提交申报。后续进展,敬请关注公司披露的相关信息。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657839646","title":"吉贝尔:今年上半年生产经营情况正常","url":"https://stock-news.laohu8.com/highlight/detail?id=2657839646","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657839646?lang=zh_cn&edition=full","pubTime":"2026-08-06 15:34","pubTimestamp":1786001694,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔08月06日在投资者关系平台上答复投资者关心的问题。无论上半年业绩向好还是承压,我们中小投资者都愿意坦然接受。谢谢吉贝尔回复:尊敬的投资者,您好!今年上半年,公司围绕生产经营计划,有序开展各项工作,生产经营情况正常,具体情况敬请关注公司将于2026年8月28日披露的《公司2026年半年度报告》。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080600020628.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657056307","title":"股市必读:吉贝尔(688566)8月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2657056307","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657056307?lang=zh_cn&edition=full","pubTime":"2026-08-05 02:25","pubTimestamp":1785867913,"startTime":"0","endTime":"0","summary":"截至2026年8月4日收盘,吉贝尔报收于24.53元,上涨0.53%,换手率0.58%,成交量1.17万手,成交额2886.62万元。董秘最新回复投资者: 请问截止2026年7月31日股东人数是多少?截至2026年7月31日收市,公司股东总数为7,619户。公司股东情况敬请关注公司披露的定期报告。当日关注点交易信息汇总:8月4日主力资金净流出264.76万元,占总成交额9.17%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656453289","title":"吉贝尔:截至2026年7月31日收市,公司股东总数为7,619户","url":"https://stock-news.laohu8.com/highlight/detail?id=2656453289","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656453289?lang=zh_cn&edition=full","pubTime":"2026-08-04 18:18","pubTimestamp":1785838694,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔(688566)08月04日在投资者关系平台上答复投资者关心的问题。投资者提问:请问截止2026年7月31日股东人数是多少?谢谢吉贝尔回复:尊敬的投资者,您好!截至2026年7月31日收市,公司股东总数为7,619户。公司股东情况敬请关注公司披露的定期报告。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080400031646.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656319625","title":"每周股票复盘:吉贝尔(688566)获新型紫杉烷类化合物专利","url":"https://stock-news.laohu8.com/highlight/detail?id=2656319625","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656319625?lang=zh_cn&edition=full","pubTime":"2026-08-02 03:21","pubTimestamp":1785612069,"startTime":"0","endTime":"0","summary":"截至2026年7月31日收盘,吉贝尔报收于24.35元,较上周的23.1元上涨5.41%。本周,吉贝尔7月31日盘中最高价报24.68元。本周关注点公司公告汇总:获得“一种新型紫杉烷类化合物的制备方法、应用”发明专利公司公告汇总江苏吉贝尔药业股份有限公司近日获得1项国家知识产权局颁发的发明专利证书,专利名称为“一种新型紫杉烷类化合物的制备方法、应用”,专利号ZL 2024 1 0472632.1,申请日为2023年4月13日,授权公告日为2026年7月28日。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080200001075.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655675800","title":"股市必读:新发布《吉贝尔关于获得发明专利的自愿性披露公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2655675800","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655675800?lang=zh_cn&edition=full","pubTime":"2026-07-31 02:31","pubTimestamp":1785436269,"startTime":"0","endTime":"0","summary":"截至2026年7月30日收盘,吉贝尔报收于23.77元,下跌0.34%,换手率0.59%,成交量1.19万手,成交额2829.71万元。公司公告汇总吉贝尔关于获得发明专利的自愿性披露公告江苏吉贝尔药业股份有限公司近日获得1项国家知识产权局颁发的发明专利证书,专利名称为“一种新型紫杉烷类化合物的制备方法、应用”,专利号ZL 2024 1 0472632.1,申请日为2023年4月13日,授权公告日为2026年7月28日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026073100001829.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655108865","title":"吉贝尔:二级市场股价受多重因素影响","url":"https://stock-news.laohu8.com/highlight/detail?id=2655108865","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655108865?lang=zh_cn&edition=full","pubTime":"2026-07-29 17:51","pubTimestamp":1785318668,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔07月29日在投资者关系平台上答复投资者关心的问题。谢谢吉贝尔回复:尊敬的投资者,您好!二级市场股价受多重因素影响,短期市场走势存在周期性波动。感谢您提出的宝贵建议,如公司未来涉及相关事项,将根据有关规定及时履行信息披露义务,有关信息以公司在指定信息披露媒体上披露的相关信息为准。本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900029757.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654163810","title":"吉贝尔:公司主营业务持续发展,总体经营情况良好","url":"https://stock-news.laohu8.com/highlight/detail?id=2654163810","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654163810?lang=zh_cn&edition=full","pubTime":"2026-07-27 17:27","pubTimestamp":1785144436,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔07月27日在投资者关系平台上答复投资者关心的问题。每次询问贵公司,总是回复做好企业,提升价值。希望贵公司能够重视二级市场,拿出实际行动。近年来,公司主营业务持续发展,总体经营情况良好,基本面持续夯实;同时我们也认识到,二级市场股价除企业自身经营外,还受外部环境、资金偏好、市场情绪等多重因素影响,短期市场走势存在周期性波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072700022397.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653762333","title":"股市必读:吉贝尔(688566)7月22日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2653762333","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653762333?lang=zh_cn&edition=full","pubTime":"2026-07-23 01:14","pubTimestamp":1784740454,"startTime":"0","endTime":"0","summary":"截至2026年7月22日收盘,吉贝尔报收于24.4元,下跌0.33%,换手率1.32%,成交量2.64万手,成交额6558.66万元。董秘最新回复投资者: 请问七月二十日股东人数,谢谢董秘: 尊敬的投资者,您好!截至2026年7月20日收市,公司股东总数为7,877户。公司股东情况敬请关注公司披露的定期报告。当日关注点交易信息汇总:7月22日主力资金净流出804.32万元,游资资金净流出345.82万元,散户资金净流入1150.14万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072300001307.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653275993","title":"吉贝尔:公司将持续聚焦主营业务,夯实经营基本面","url":"https://stock-news.laohu8.com/highlight/detail?id=2653275993","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653275993?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:06","pubTimestamp":1784714777,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔(688566)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问:公司股价长期低迷,上市六年了,股价还在发行价附近,公司就不能回购股份注销吗,高管不能增持吗?请具体回答,别让投资者寒心,谢谢吉贝尔回复:尊敬的投资者,您好!感谢您的建议,二级市场股票价格波动受多重因素影响,公司及管理层持续关注。公司将持续聚焦主营业务,夯实经营基本面,提升内在核心价值,提高投资者回报。有关公司具体事项,以公司在指定信息披露媒体上披露的相关信息为准。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200037533.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653759544","title":"吉贝尔:截至2026年7月20日收市,公司股东总数为7,877户","url":"https://stock-news.laohu8.com/highlight/detail?id=2653759544","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653759544?lang=zh_cn&edition=full","pubTime":"2026-07-22 18:03","pubTimestamp":1784714598,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔(688566)07月22日在投资者关系平台上答复投资者关心的问题。投资者提问:请问七月二十日股东人数,谢谢吉贝尔回复:尊敬的投资者,您好!截至2026年7月20日收市,公司股东总数为7,877户。公司股东情况敬请关注公司披露的定期报告。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072200037449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652723069","title":"每周股票复盘:吉贝尔(688566)股东户数增6.51%至7938户","url":"https://stock-news.laohu8.com/highlight/detail?id=2652723069","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652723069?lang=zh_cn&edition=full","pubTime":"2026-07-19 02:34","pubTimestamp":1784399650,"startTime":"0","endTime":"0","summary":"截至2026年7月17日收盘,吉贝尔报收于25.0元,较上周的26.15元下跌4.4%。本周,吉贝尔7月13日盘中最高价报27.96元。吉贝尔当前最新总市值50.28亿元,在化学制药板块市值排名89/149,在两市A股市值排名2945/5199。本周关注点股本股东变化:截至2026年7月10日股东户数为7938户,较前期增长6.51%股本股东变化股东户数变动截至2026年7月10日,公司股东户数为7938.0户,较6月18日增加485.0户,增幅6.51%。户均持股数量由上期的2.7万股下降至2.53万股,户均持股市值为66.25万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071900000782.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652429940","title":"股市必读:吉贝尔(688566)股东户数0.79万户,较上期增加6.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2652429940","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652429940?lang=zh_cn&edition=full","pubTime":"2026-07-17 02:08","pubTimestamp":1784225294,"startTime":"0","endTime":"0","summary":"截至2026年7月16日收盘,吉贝尔报收于27.0元,下跌0.74%,换手率1.68%,成交量3.37万手,成交额9109.76万元。股本股东变化:截至2026年7月10日,吉贝尔股东户数为7938.0户,较6月18日增加485.0户,增幅6.51%;户均持股由2.7万股降至2.53万股。户均持股数量由上期的2.7万股减少至2.53万股,户均持股市值为66.25万元。截至2026年7月10日收市,公司股东总数为7,938户。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071700001120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651041241","title":"吉贝尔:持续聚焦主营业务,夯实经营基本面","url":"https://stock-news.laohu8.com/highlight/detail?id=2651041241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651041241?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:21","pubTimestamp":1784190083,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔(688566)07月16日在投资者关系平台上答复投资者关心的问题。投资者提问:公司股价长期低迷,有没有提振股价具体措施,谢谢吉贝尔回复:尊敬的投资者,您好!二级市场股票价格波动受多重因素影响,公司及管理层持续关注。公司将持续聚焦主营业务,夯实经营基本面,提升内在核心价值,提高投资者回报。有关公司具体事项,以公司在指定信息披露媒体上披露的相关信息为准。感谢您的关注!本文数据来源于上海证券交易所e互动,仅供参考不构成投资建议。责任编辑:刘浩然","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600026090.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651412473","title":"吉贝尔:JJH201601已完成I期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2651412473","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651412473?lang=zh_cn&edition=full","pubTime":"2026-07-16 16:18","pubTimestamp":1784189899,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔07月16日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,作为持股投资者,十分关注公司抗肿瘤创新管线,JJH201601单药IIa期临床完成入组后,现阶段试验随访、疗效与安全性数据整理进度如何,是否有阶段性数据对外披露计划?目前,抗肿瘤新药JJH201601已完成I期临床试验,临床试验结果显示安全性好,疗效确切,目前正在开展IIa期临床试验,已完成受试者入组工作,正在进行随访观察和评价。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026071600026029.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649676300","title":"股市必读:吉贝尔(688566)7月6日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2649676300","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649676300?lang=zh_cn&edition=full","pubTime":"2026-07-07 02:34","pubTimestamp":1783362853,"startTime":"0","endTime":"0","summary":"截至2026年7月6日收盘,吉贝尔报收于26.43元,下跌0.56%,换手率1.53%,成交量3.07万手,成交额8209.1万元。目前,抗抑郁新药JJH201501生产批件申报工作正在按照有关申报要求有序推进中,目前处于申报前的会议沟通阶段,公司将积极做好相关工作,有关具体进展情况,敬请关注公司后续披露的相关信息。投资者: 董秘您好,JJH201501已于2025年10月完成III期临床试验,至今数月,想咨询:上市申报资料是否全部收尾,预计何时正式递交CDE?","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070700001199.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688566"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649681623","title":"吉贝尔:抗抑郁新药JJH201501生产批件申报工作正在有序推进中","url":"https://stock-news.laohu8.com/highlight/detail?id=2649681623","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2649681623?lang=zh_cn&edition=full","pubTime":"2026-07-06 18:21","pubTimestamp":1783333267,"startTime":"0","endTime":"0","summary":"证券之星消息,吉贝尔07月06日在投资者关系平台上答复投资者关心的问题。目前,抗抑郁新药JJH201501生产批件申报工作正在按照有关申报要求有序推进中,目前处于申报前的会议沟通阶段,公司将积极做好相关工作,有关具体进展情况,敬请关注公司后续披露的相关信息。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070600028390.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648526399","title":"股市必读:吉贝尔(688566)7月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2648526399","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2648526399?lang=zh_cn&edition=full","pubTime":"2026-07-02 04:16","pubTimestamp":1782936974,"startTime":"0","endTime":"0","summary":"截至2026年7月1日收盘,吉贝尔报收于26.52元,上涨3.63%,换手率1.88%,成交量3.78万手,成交额9881.23万元。董秘最新回复投资者: 请问,截至2026年6月30日公司的股东总数是多少?报告期末的股东人数属于定期报告应当披露的信息,为保证信息披露的公平性,公司将在2026年半年度报告中披露上述信息。交易信息汇总资金流向7月1日主力资金净流入354.17万元,占总成交额0.0%;游资资金净流出1513.71万元,占总成交额0.0%;散户资金净流入1159.55万元,占总成交额0.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026070200001971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688566","BK0239"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1786585986893,"stockEarnings":[{"period":"1week","weight":0.0406},{"period":"1month","weight":-0.0401},{"period":"3month","weight":-0.0387},{"period":"6month","weight":-0.1064},{"period":"1year","weight":-0.162},{"period":"ytd","weight":-0.1241}],"compareEarnings":[{"period":"1week","weight":0.0176},{"period":"1month","weight":0.0084},{"period":"3month","weight":-0.0553},{"period":"6month","weight":-0.0332},{"period":"1year","weight":0.0766},{"period":"ytd","weight":-0.0056}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"江苏吉贝尔药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"8311人(较上一季度增加9.08%)","perCapita":"24197股","listingDate":"2020-05-18","address":"江苏省镇江市润州区高新技术产业开发园区","registeredCapital":"20110万元","survey":" 江苏吉贝尔药业股份有限公司的主营业务是药物研发、生产、销售。公司的主要产品是利可君片、尼群洛尔片、玉屏风胶囊、醋氯芬酸肠溶片。公司是国家级专精特新“小巨人”企业。","listedPrice":23.69},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉贝尔,688566,吉贝尔股票,吉贝尔股票老虎,吉贝尔股票老虎国际,吉贝尔行情,吉贝尔股票行情,吉贝尔股价,吉贝尔股市,吉贝尔股票价格,吉贝尔股票交易,吉贝尔股票购买,吉贝尔股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉贝尔(688566)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉贝尔(688566)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}